Eleotin Chrono
Natural health product licensed in Canada
- Licence holder
- Eastwood Bio-Medical Research Inc.
- NPN or DIN-HM
- 80086916
- Status
- Active licence
- Licence date
- 6 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 90 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 90 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rumex crispus Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 160 milligramme | 40 milligramme | Not calculated |
| Arctium lappa Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 milligramme | 40 milligramme | Not calculated |
| Zinc Source : Oxyde de zinc | 10 milligramme | 30,000 µg |
| Magnésium Source : Oxyde de magnésium | 25 milligramme | 75,000 µg |
| Vitamine A Source : Palmitate de vitamine A | 1,000 Micrograms Retinol activity equivalents | Not calculated |
| Thiamine Source : Salvia hispanica - graine | 30 milligramme | 90,000 µg |
| Riboflavine Source : Chenopodium quinoa - Graine | 30 milligramme | 90,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 30 milligramme | 90,000 µg |
| Niacine Source : Niacine | 100 milligramme | Not calculated |
| Biotine Source : Chlorella vulgaris - cellule brisée | 100 microgrammes | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 100 mg AT | Not calculated |
| Calcium Source : Carbonate de calcium | 25 milligramme | 75,000 µg |
| Sélénium Source : Sélénite de sodium | 60 microgrammes | Not calculated |
| Chrome Source : Picolinate de chrome (III) | 60 microgrammes | Not calculated |
| L-Lysine Source : Glycine max - Graine | 75 milligramme | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 milligramme | 30 milligramme | Not calculated |
| Vitamine C Source : Zea mays - Graine | 50 milligramme | 150,000 µg |
| Vitamine C Source : Acide ascorbique | 50 milligramme | 150,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Dioxyde de silicium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 days |
Uses authorised in Canada
Traditionally used in Herbal Medicine as an alterative to help remove accumulated waste products via the kidneys, skin and mucus membranes. Helps in connective tissue formation. Helps to maintain healthy skin, skin membranes, eyesight, immune function. Helps in the development and maintenance of bones, teeth, and night vision. Helps the body to metabolize carbohydrates, proteins, and fats. Source of/An antioxidant that helps protect cells against the oxidative effect of cell damage caused by free radicals. Provides support for healthy glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have diabetes. If you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance, consult a health care practitioner prior to use. If you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications, consult a health care practitioner prior to use. If you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use. Laxative effect may occur. Discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. If you have cancer, consult a health care practitioner prior to use. If you have cardiovascular disease or diabetes, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you are pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blokage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea.
Source
Official Health Canada record, licence 80086916
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.